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ABSTRACT
Background: Newborn calves are agammaglobulinemic, immunosuppressed and immunologically immature at birth. The 
passive immune transfer is fundamental to protect calves against pathogens. The decay of maternal antibodies precedes the 
immune maturation at puberty enhancing the susceptibility of calves to infections caused by BVDV. Then, the objective of 
this research was to evaluate the interface between passive and active immunity for Bovine Viral Diarrhea Virus (BVDV) 
in Holstein dairy heifers in the first 13 months of age to detect susceptibility periods and establish prophylactic measures 
on prevention of Bovine Viral Diarrhea.
Materials, Methods & Results: Sera were analyzed from 585 heifers by serum neutralization (SN) and enzyme linked im-
munosorbent assay (ELISA) for the p80 protein of BVDV. Heifers were categorized according to their age by the month of 
life. Heifers were seropositive (100%) from 1st to 13th. Median of neutralizing antibodies (Ab) titers obtained from 1st up to 
13th month were 316.2; 125.9; 63.1; 50.1; 50.1; 39.8; 63.1; 63.1; 39.8; 79.4, 100.0; 74.4; and 79.4, respectively. The neutral-
izing Ab titers obtained in 1st month were different of the values observed from 2nd until 13th (P < 0.001), furthermore the Ab 
titers from 2nd month was statistical different of 4th (P = 0.01) and 6th (P = 0.05). The frequencies (%) of positive heifers for 
p80 from 1st up to 13th were 24.7; 18.2; 10.4; 11.8; 73.3; 73.8; 72.4; 58.1; 45.9; 48.4; 46.2; 43.8 and 61.5, respectively. The 
correlation observed for neutralizing Ab titers and age was negative and weak (ρ= -0.299; P < 0.001). On the other hand, the 
correlation between positive heifers for p80 and age was positive and moderate (ρ= 0.319; P < 0.001).
Discussion: The newborn calves had higher titers of neutralizing antibodies than other age groups and some calves were 
seropositive for the p80 protein. This profile points to the transfer of maternal antibodies produced by vaccination and/or 
natural exposure to BVDV. The exposure of the cows to the inactivated and live virus stimulates the production of neutral-
izing antibodies to the structural proteins of the virus, particularly the glycoprotein E2, detected by the serum neutralization 
test. The titers of serum neutralizing antibodies and the frequencies of seropositive for p80 protein decreased gradually 
from the first to the 4-6th month of life due to the metabolization of maternal immunoglobulins acquired by ingestion of 
colostrum. Frequencies of seropositive animals for protein p80 increased from the fifth month of life, which is the same 
moment that was observed declined of neutralizing maternal antibody titers. The phase of higher frequency of p80 positive 
animals coincides with greater rates of Babesiosis and Anaplasmosis. This history could justify the importance of the BVDV 
immunodepression as a risk factor for concomitant diseases. In general, the neutralizing antibody titers increased after the 
peaks of positive reactions to the p80 protein, but this moment coincides with the primo-vaccination in calves. Therefore, 
it is not possible to state the origin of these antibodies. Correlations between ages and serologic tests are consistent with 
previous data reporting the decrease in antibody titers and increase of seropositive animals for p80 protein, from the first 
month of life to puberty. In conclusion, maternal neutralizing Ab titers had gradual decreased whereas the frequency of 
positive heifers for p80 had increased values. The inversion observed between the maternal antibody titers and the increase 
in antibody for p80 indicates the moment of greatest risk for natural infections caused by BVDV.
Keywords: maternal antibodies, Bovine Diarrhea Virus (BVD), serum neutralization test, p80 protein.
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INTRODUCTION
Newborn calves are agammaglobulinemic, 
immunosuppressed and immunologically immature 
at birth. The development of immune system occurs 
slowly and gradually until it reaches a status similar to 
adults at six months after birth. Young calves depend on 
passive immunity transferred from cows as the primary 
basis for protection against diseases [5].
Maternal Ab titers for BVDV decline and 
its length depend on the amount ingested, absorbed 
and the decay rate [9]. Postnatal BVDV infections in 
calves with low levels of maternal antibodies (≤16) 
result in acute and intense disease characterized by 
hyperthermia, leukopenia, thrombocytopenia and 
diarrhea. In contrast, animals fed with colostrum de-
rived from vaccinated cows, developed mild clinical 
signs or did not express the disease after experimental 
infection [1].
Passive immunity is a double-edged sword for 
young calves: protection from diseases on one side, and 
interference with a calf’s ability to develop immunity 
to vaccine antigens on the other [3]. While passive 
immunity provides protection against disease it could 
blocks the production of serum antibodies when im-
munogens are administered to calves with maternally 
derived antibodies. However, others studies have shown 
that some immunogens can induce immunological 
memory that is not susceptible to maternal antibody 
regulation [7]. 
The decay of maternal antibodies precedes 
the immune maturation at puberty enhancing the sus-
ceptibility of calves to infections caused by BVDV. 
Then, the objective of this research was to evaluate 
the interface between passive and active immunity for 
Bovine Viral Diarrhea Virus (BVDV) in Holstein dairy 
heifers in the first 13 months of age to detect suscepti-
bility periods and establish prophylactic measures on 
prevention of Bovine Viral Diarrhea.
MATERIALS AND METHODS
Animals and sample collection
The study was performed with 585 Holstein 
heifers on a commercial dairy herd in a high produc-
tion system with average milk production of 66,000 L/
day, located in the state of São Paulo, Brazil, between 
coordinates 22º 10’to 22º 30’ south latitude and 47º 15’ 
to 47º 30’ west longitude.
The herd was composed of approximately 
3,700 Holstein cows, with 1,750 producing around 
38.5 L of milk production per day and 95 calves from 
1 up to 70 days of life. Right after birth, the animals 
are kept singly in elevated calf hutches (1 m2) in a calf 
barn with an area of 112.5 m2 and a height of 4.5 m 
(1.18 animal unit/m2). After this period, the animals are 
housed into confinement paddocks where they remain 
until the next delivery date, being transferred then to 
the maternity barn. After delivery, lactating cows are 
kept in a barn with cross ventilation system and when 
they reach the dry period they are reallocated to the 
free stall barn.
The births were assisted and calves were 
separated immediately after birth and transferred to 
individual pens. Four liters of frozen colostrum of 
the first milking were administered into two feedings 
during the first 12 h after birth. The frozen colostrum 
used was from multiparous donors, whose immune 
quality was estimated by colostrometer (≥50 g/L of 
immunoglobulin). The thawing was performed in 
a water bath (45-50°C) until the colostrum reached 
37°C. Then, the calves were fed with six liters of milk 
replacer (Lacthor®)1 per day.
The vaccination protocol from the farm starts 
with calves on 120 days of age with booster at 150 
days, followed by semi-annual revaccination held 
in April and October. The commercial vaccine used 
was composed by inactivated strains of BVDV type 
1 (5960) and type 2 (53637); live/thermosensitive 
BoHV-1 (Cooper) and BPIV-3 (RLB 103); live/
attenuated BRSV (375) and Leptospira spp., as-
sociated with Quil A, cholesterol and Amphigen as 
adjuvants.
Blood samples were collected by puncture of 
the external jugular vein, using vacuum blood tubes 
without anticoagulant (20 mL) to carry out the serologi-
cal tests. In the laboratory, samples were centrifuged 
at 800 x g for 15 min and the serum obtained was 
transferred to micro tubes and stored at -80°C.
Serological test
The serum neutralization test (SN) was ac-
complished using 96-well polystyrene plates [14]. 
The serum was serially diluted in log2 steps from 
1:10 (BVDV-NADL) using minimal essential me-
dium (MEM) containing 1% to 2% of antibiotics. 
The diluted samples were added in duplicate to 
wells in the plate. Then, it was added 50 µL con-
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taining TCID50/100 µL (50% tissue culture infective 
doses) from BVDV. After, plates were incubated 
for 1h for BVDV at 37°C in incubator with 5% 
CO2. Subsequently, Madin-Darby bovine kidney 
(MDBK) cell suspension was added to each well. 
Plates were once more incubated at 37°C with 5% 
CO2 for 4 to 5 days.
Infectivity was measured based on the cyto-
pathic effect (CPE) visible in the cell monolayer on 
the plates by using an inverted microscope. Antibody 
titer was expressed as the highest dilution of the serum 
that completely inhibited the infectivity and therefore 
the CPE in both the wells of each dilution.
Antibodies against p80 protein of BVDV were 
detected by enzyme linked immunosorbent assay 
(ELISA) using a commercial kit (SERELISA® BVD 
p80 Ab Mono blocking kit, Synbiotic)2. The procedures 
and interpretation of the reactions were performed ac-
cording to the manufacturer’s recommendations.
Statistical analysis
Statistical analysis was performed using 
the SPSS 20.0 program3. The antibody titers were 
converted to base-2 logarithm, however presented 
non-normal distribution by Shapiro-Wilk and Kol-
mogorov-Smirnov tests. The medians of the titers 
were calculated and differences between moments 
were obtained using the Kruskal-Wallis test. Finally, 
the values were converted in antilog by the expres-
sion = 2a, where “a” is the median of antibody titers 
in Log2.
The frequencies of positive and negative 
animals for BVDV p80 protein were calculated. The 
chi-square test was used to detect differences in the 
frequencies (%) between times.
Correlations between age groups and serologi-
cal tests were calculated using Spearman correlation 
test (P < 0.05). The results were interpreted according 
to the classification of statistical authors [6], in which 
the closer to 1 (regardless of sign) is the Spearman cor-
relation coefficient (ρ), the greater will be the degree 
of statistical dependence. This dependence may be 
weaker when ρ =0.1 to 0.3; moderate with ρ =0.4 to 
0.6 and strong when ρ =0.7 to 1.0.
RESULTS
All the animals evaluated (n=585), from the 
1st to the 13th month of life, were seropositive (100%) 
for BVDV by SN test.
The medians for the antibody titers obtained 
in the first thirteen months of life were, respectively, 
316.2; 125.9; 63.1; 50.1; 50.1; 39.8; 63.1; 63.1; 39.8; 
79.4, 100.0; 74.4; and 79.4. Gradual decrease was 
noted in the value from the first to sixth month of life. 
Differences in the Ab titers presented by newborn 
calves could be detected when compared to other age 
groups. Calves with two months of age had higher 
Ab titers than those with four and six months of age 
(Table 1).
Table 1. Median of specific antibody titers for BVDV in serum 
of Holstein heifers, from 1st up to 13th month of life.
Age (months) Log2 Antilog Range
1 8.3b-m 316.2 10-631
2 7.3a.d.f 125.9 10-631
3 6.3a 63.1 10-631
4 5.3a.b 50.1 10-631
5 6.3a 50.1 10-631
6 5.3a.b 39.8 10-631
7 6.3a 63.1 10-631
8 6.3a 63.1 10-631
9 5.3a 39.8 10-631
10 6.3a 79.4 10-631
11 6.3a 100.0 10-631
12 6.3a 79.4 10-316
13 6.3a 79.4 10-631
Lowercase letters in the same column show differences between 
the ages obtained by Kruskal Wallis test with (a) different values 
from 1st; (b) 2nd; (c) 3rd; (d) 4th; (e) 5th; (f) 6th; (g) 7th; (h) 8th; (i) 9th; 
(j) 10th; (k) 11th; (l) 12th; (m) 13th months of life when P < 0.05.
The proportions of positive heifers for p80 
were 24.7; 18.2; 10.4; 11.8; 73.3; 73.8; 72.4; 58.1; 
45.9; 48.4; 46.2; 43.8 and 61.5, respectively from 
the first to 13th months of age (Table 2). A gradual 
decrease in the frequencies could be observed from 
the first to fourth month of life. The peak of positive 
reactions was noted between 5 and 7 months and then 
the values decreased and become relatively constant. 
The differences in the frequencies between the months 
are shown in Table 3.
The correlation observed between Ab titers 
and the different age groups was negative and weak 
ρ= -0.299 (P < 0.001). In contrast, the correlation 
obtained between the positives animals for p80 
protein and ages was moderate positive ρ =0.319 
(P < 0.001).
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Table 2. Absolut values and frequencies for p80 protein in Holstein heifers obtained by direct immunoenzymatic test.
ELISA p80 
Age 
(months)
Positive Negative
Absolute 
values Frequencies (%)
Absolute 
values Frequencies (%)
1 22 24.7 67 75.3
2 14 18.2 63 81.8
3 7 10.4 60 89.6
4 6 11.8 45 88.2
5 44 73.3 16 26.7
6 31 73.8 11 26.2
7 42 72.4 16 27.6
8 18 58.1 13 41.9
9 17 45.9 20 54.1
10 15 48.4 16 51.6
11 6 46.2 7 53.8
12 7 43.8 9 56.3
13 8 61.5 5 38.5
Table 3. Significant differences obtained between months to positive and negative frequencies for BVDV 
p80 protein in Holstein heifers.
Age (months) 1 2 3 4 5 6 7
3 0.0479       
5 0.001 0.001 0.0001 0.0001    
6 0.001 0.001 0.0001 0.0001    
7 0.001 0.001 0.0001 0.0001  0.0214  
8  0.001 0.0001 0.0001  0.0478  
9 0.0327 0.0038 0.0002 0.0008 0.0126 0.0214 0.0175
10 0.0256 0.003 0.0001 0.0006 0.0331   
11   0.0066 0.0148    
12  0.0258 0.002 0.0056    
13 0.0166 0.0026 0.0001 0.0005    
Significances between group ages to frequencies (%) obtained by Chi-square test when P < 0.05.
DISCUSSION
This research evaluated the interface be-
tween passive and active immunity to BVDV of 
Holstein heifers (n = 585) raised in confinement 
dairy production system from the first to the 13th 
month of life. 
The infection due to natural exposure to the 
virus was investigated by detection of specific anti-
bodies against the nonstructural protein p80 (NS3). 
This polypeptide is produced by cytopathic BVDV 
during the viral replication process and therefore 
stimulates the production of antibodies only in natu-
rally infected animals or vaccinated with modified 
live virus [10,11]. The dairy farm selected for this 
research never used live vaccines for BVDV due to 
prohibitive legislation in our country. Thus, the pres-
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ence of seropositive animals for p80 indicates the 
virus circulation within the herd.
The newborn calves had higher titers of neu-
tralizing antibodies than other age groups and also 
some calves were seropositive for the p80 protein. 
This profile points to the transfer of maternal antibod-
ies produced by vaccination and/or natural exposure 
to BVDV. The exposure of the cows to the inactivated 
and live virus stimulates the production of neutral-
izing antibodies to the structural proteins of the virus, 
particularly the glycoprotein E2, detected by the serum 
neutralization test [13].
The titers of serum neutralizing antibodies 
and the frequencies of seropositive for p80 protein 
decreased gradually from the first to the 4-6th month 
of life due to the metabolization of maternal immuno-
globulins acquired by ingestion of colostrum. Maternal 
antibodies was detected in the circulation of calves up 
to six months of life [12], but the persistence of these 
immunoglobulins may be higher depending on the 
quality of ingested colostrum [9].
Frequencies of seropositive animals for pro-
tein p80 increased from the fifth month of life, which 
is the same moment that was observed declined of 
neutralizing maternal antibody titers. At this mo-
ment, the median observed for neutralizing antibody 
titers was 50. Researchers demonstrated that calves 
with antibody titers above 16 developed mild disease 
after experimental infection with BVDV [1]. The 
presence of others management-related risk factors 
could justify the high frequency of positive animals 
for BVDV presenting higher antibody titers than 
those protectors.
The calves are kept in individual pens from 
birth up to 70 days of life and then are re-allocated to 
barns in groups around 20 animals. From four months 
old, all the animals are transferred to an area of col-
lective confinement, where they remain until the first 
artificial insemination. Thus, the insertion and greater 
contact between animals in this last stage of heifers 
raising may have been primordial in the spread of 
BVDV in this age group. It is also worth noting that 
stress resulting from the re-socialization and feed man-
agement contributes for the BVDV epidemiology, as 
the decrease of maternal antibodies does.
The phase of higher frequency of p80 positive 
animals coincides with greater rates of Babesiosis 
and Anaplasmosis. This history could justify the 
importance of the BVDV immunodepression as a risk 
factor for concomitant diseases.
BVDV infects neutrophils, monocytes and 
dendritic cells [2]. Neutrophils from infected ani-
mals have been reported to reduce phagocytosis and 
microbicidal activity, which persists during the first 
two weeks post-infection [15]. The lymphocytes 
tropism by the virus results in depletion of lymphoid 
organs and immunodepression [8]. This imbalance 
in the innate immune response, as well as deple-
tion of the lymphocytes subpopulations, promotes 
and exacerbates any concomitant disease to BVDV 
infection [4].
In general, the neutralizing antibody titers 
increased after the peaks of positive reactions to the 
p80 protein, but this moment coincides with the primo-
vaccination in calves. Therefore, it is not possible to 
state the origin of these antibodies.
Correlations between ages and serologic tests 
are consistent with previous data reporting the decrease 
in antibody titers and increase of seropositive animals 
for p80 protein, from the first month of life to puberty. 
CONCLUSION
In conclusion, maternal neutralizing Ab ti-
ters had gradual decreased whereas the frequency 
of positive heifers for p80 had increased values. The 
inversion observed between the maternal antibody 
titers and the increase in antibody for p80 indicates 
the moment of greatest risk for natural infections 
caused by BVDV.
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